Moderna, Inc. Share Price and Company Fundamentals
Last traded: Today at 8:00 PM
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
|Industry / Sector||Biotechnology / Healthcare|
|Full time employees||3400|
|Mailing address||200 Technology Square Cambridge MA 02139 United States|
|Phone / Fax||617 714 6500 /|
Moderna, Inc. paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.MRNA dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
MRNA's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
As of Aug 2022, following are the company executives and directors listed on Moderna, Inc..
|Dr. Noubar B. Afeyan Ph.D.||Co-Founder, Independent Non Exec. Chairman & Member of Technology Advisory Board||58||1.12M|
|Mr. Stephane Bancel||CEO & Director||48||3.16M|
|Dr. Stephen Hoge M.D.||Pres||45||1.8M|
|Mr. David W. Meline||Chief Financial Officer||64||1.24M|
|Ms. Shannon Thyme Klinger||Chief Legal Officer & Corp. Sec.||50||1.76M|
|Mr. Juan Andres||Chief Technical Operations & Quality Officer||56||1.6M|
|Dr. John V. W. Reynders Ph.D.||Chief Information Officer|
|Dr. Melissa J. Moore Ph.D.||Chief Scientific Officer & Member of Scientific Advisory Board|
|Ms. Lavina Talukdar CFA||Sr. VP & Head of Investor Relations|
|Colleen Hussey||Sr. Director of Corp. Communications|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Moderna, Inc. is and its enterprise value is .
The MRNA's stocks Beta value is 1.60 making it 60% more volatile compared to NASDAQ market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Moderna, Inc. (NASDAQ:MRNA) Frequently Asked Questions
1. What is Moderna, Inc.'s Stock Symbol?
Moderna, Inc. trades on NASDAQ under the ticker symbol "MRNA".
2. What is Moderna, Inc.'s stock price today?
One share of MRNA stock can currently be purchased for approximately $171.81.
3. How can I contact Moderna, Inc.?
Moderna, Inc.'s mailing address is 200 Technology Square Cambridge MA 02139 United States. The company can be reached via phone at 617 714 6500.
4. What is Moderna, Inc.'s official website?
The official website of Moderna, Inc. is https://www.modernatx.com.